Retrospective cohort study on risk factors for developing ischemic stroke.

IF 2.4 Q3 PHARMACOLOGY & PHARMACY
Pharmacy Practice-Granada Pub Date : 2022-07-01 Epub Date: 2022-06-22 DOI:10.18549/PharmPract.2022.3.2682
Adel Sadeq, Mohamed A Baraka, Amar Hamrouni, Asim Ahmed Elnour
{"title":"Retrospective cohort study on risk factors for developing ischemic stroke.","authors":"Adel Sadeq,&nbsp;Mohamed A Baraka,&nbsp;Amar Hamrouni,&nbsp;Asim Ahmed Elnour","doi":"10.18549/PharmPract.2022.3.2682","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is a paucity of studies describing the risk factors for developing ischemic stroke in our region.</p><p><strong>Objective: </strong>The objective of the current study was to delineate the potential risk factors for the development of ischemic stroke.</p><p><strong>Methods: </strong>We have conducted a retrospective cohort hospitalbased study that has enrolled 231 subjects. The subjects have had presented to the emergency department in a tertiary hospital in the United Arab Emirates. Subjects were diagnosed with ischemic stroke within 24 hours of presentation.</p><p><strong>Outcome measure: </strong>The main outcome measure was the development of ischemic stroke during an indexed hospital visit.</p><p><strong>Results: </strong>The mean age was 47.5 ±3.2 with a higher preponderance of males over females (60.9%) and 48.1% were ≥ 65 years. The final logistic regression model for the development of ischemic stroke contains seven variables. In descending order, the seven predictive risk factors for the development of ischemic stroke were: hypertension (OR 6.1, CI 2.4-9.5; P = 0.029), coronary artery disease (OR 4.2, 3.7-9.1; P = 0.038), low physical activity (OR 4.2, CI 2.1-9.1; P = 0.035), history of previous stroke (OR 4.1, 1.4-3.4; P = 0.033), atrial fibrillation (OR 3.2, CI 2.6-8.2; P = 0.017), family history of stroke (OR 3.1, 1.3-6.9; P = 0.042) and diabetes mellitus (OR 2.7, CI 1.25-6.1; P = 0.035). The specificity of the model was 58.1%; the sensitivity was 86.1%, and the overall accuracy was 75.7%.</p><p><strong>Conclusion: </strong>It is prudent to control modifiable risk factors for the development of strokes such as hypertension, diabetes, atrial fibrillation, coronary artery disease, and low physical activity.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"20 3","pages":"2682"},"PeriodicalIF":2.4000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/47/58/pharmpract-20-2682.PMC9851832.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacy Practice-Granada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18549/PharmPract.2022.3.2682","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Background: There is a paucity of studies describing the risk factors for developing ischemic stroke in our region.

Objective: The objective of the current study was to delineate the potential risk factors for the development of ischemic stroke.

Methods: We have conducted a retrospective cohort hospitalbased study that has enrolled 231 subjects. The subjects have had presented to the emergency department in a tertiary hospital in the United Arab Emirates. Subjects were diagnosed with ischemic stroke within 24 hours of presentation.

Outcome measure: The main outcome measure was the development of ischemic stroke during an indexed hospital visit.

Results: The mean age was 47.5 ±3.2 with a higher preponderance of males over females (60.9%) and 48.1% were ≥ 65 years. The final logistic regression model for the development of ischemic stroke contains seven variables. In descending order, the seven predictive risk factors for the development of ischemic stroke were: hypertension (OR 6.1, CI 2.4-9.5; P = 0.029), coronary artery disease (OR 4.2, 3.7-9.1; P = 0.038), low physical activity (OR 4.2, CI 2.1-9.1; P = 0.035), history of previous stroke (OR 4.1, 1.4-3.4; P = 0.033), atrial fibrillation (OR 3.2, CI 2.6-8.2; P = 0.017), family history of stroke (OR 3.1, 1.3-6.9; P = 0.042) and diabetes mellitus (OR 2.7, CI 1.25-6.1; P = 0.035). The specificity of the model was 58.1%; the sensitivity was 86.1%, and the overall accuracy was 75.7%.

Conclusion: It is prudent to control modifiable risk factors for the development of strokes such as hypertension, diabetes, atrial fibrillation, coronary artery disease, and low physical activity.

缺血性脑卒中危险因素的回顾性队列研究。
背景:在我们地区,很少有研究描述缺血性中风的危险因素。目的:本研究的目的是确定缺血性脑卒中发生的潜在危险因素。方法:我们进行了一项基于医院的回顾性队列研究,共纳入231名受试者。受试者已被送往阿拉伯联合酋长国一家三级医院的急诊科。受试者在发病后24小时内被诊断为缺血性中风。结果测量:主要的结果测量是在指数化的医院就诊期间缺血性卒中的发展。结果:平均年龄为47.5±3.2岁,男性占60.9%,≥65岁者占48.1%。缺血性卒中发展的最终逻辑回归模型包含七个变量。缺血性卒中发生的七个预测危险因素按降序排列:高血压(OR 6.1,CI 2.4-9.5;P=0.029)、冠状动脉疾病(OR 4.2,CI 3.7-9.1;P=0.038)、体力活动量低(OR 4.2、CI 2.1-9.1;P=0.035)、既往卒中史(OR 4.1,CI 1.4-3.4;P=0.033)、心房颤动(OR 3.2,CI 2.6-8.2;P=0.017),脑卒中家族史(OR 3.1,1.3-6.9;P=0.042)和糖尿病家族史(OR2.7,CI 1.25-6.1;P=0.035)。该模型的特异性为58.1%;其敏感性为86.1%,总体准确率为75.7%。结论:控制高血压、糖尿病、心房颤动、冠状动脉疾病和低体力活动等可改变的卒中发生危险因素是谨慎的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmacy Practice-Granada
Pharmacy Practice-Granada PHARMACOLOGY & PHARMACY-
CiteScore
3.90
自引率
4.00%
发文量
113
审稿时长
20 weeks
期刊介绍: Pharmacy Practice is a free full-text peer-reviewed journal with a scope on pharmacy practice. Pharmacy Practice is published quarterly. Pharmacy Practice does not charge and will never charge any publication fee or article processing charge (APC) to the authors. The current and future absence of any article processing charges (APCs) is signed in the MoU with the Center for Pharmacy Practice Innovation (CPPI) at Virginia Commonwealth University (VCU) School of Pharmacy. Pharmacy Practice is the consequence of the efforts of a number of colleagues from different Universities who belief in collaborative publishing: no one pays, no one receives. Although focusing on the practice of pharmacy, Pharmacy Practice covers a wide range of pharmacy activities, among them and not being comprehensive, clinical pharmacy, pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信